Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Rates of glaucomatous visual field progression in a large Indian cohort
Author Affiliations & Notes
  • Ronnie George
    Sankara Nethralaya, Chennai, Tamil Nadu, India
  • Georgin Jacob
    Carl Zeiss India Pvt Ltd, Bangalore, Karnataka, India
  • Raghu Prasad
    Carl Zeiss India Pvt Ltd, Bangalore, Karnataka, India
  • reni philip
    Sankara Nethralaya, Chennai, Tamil Nadu, India
  • chitralekha SD
    Sankara Nethralaya, Chennai, Tamil Nadu, India
  • Footnotes
    Commercial Relationships   Ronnie George Carl Zeiss India, Code F (Financial Support); Georgin Jacob Carl Zeiss India, Code E (Employment); Raghu Prasad Carl Zeiss India, Code E (Employment); reni philip None; chitralekha SD None
  • Footnotes
    Support  Carl Zeiss India (Bangalore) Pvt Ltd
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4798. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ronnie George, Georgin Jacob, Raghu Prasad, reni philip, chitralekha SD; Rates of glaucomatous visual field progression in a large Indian cohort. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4798.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To report the rates of visual field progression based on Glaucoma Progression analysis of Humphrey Visual Field analysis

Methods : We included eyes with at least 5 visual fields from a large cohort of patients from a tertiary care hospital. Progression was defined based on Glaucoma progression analysis using both trend and event analysis at their last visit. Eyes with “Likely progression” on Event analysis or statistically significant slope of progression on trend analysis were classified as progressing. Demographic and visual field parameters were compared between both progressing and non-progressing eyes.

Results : We included 125935 fields of 16497 eyes( 9932 patients ). Mean age was 51.9(Sd: 15.2) years and the majority were males. There was an average of 7.6 fields per eye. Mean baseline MD was -9.7(SD:8.3), PSD was 5.46(SD: 3.85) and VFI was 77.4 (SD: 26.3). 4396 ( 26.6%) eyes of 3540 patients showed progression on GPA event analysis as defined. 4060(24.6%) eyes of 3261 patients showed progression GPA trend analysis.
The mean age of non-progressing patients at baseline was older at 53.0(SD:14.6) years compared to the progressing eyes ( 51.4 (SD: 15.5 years)) (P<0.001)) . The mean baseline VFI(75.1(SD: 28.3) vs 83.9 (SD: 18.3), baseline MD(-10.4(SD:8.9) vs -7.6(SD:6.1) and baseline PSD(5.6(SD:4) vs 5.1(SD: 3.5) values were worse in the non progressing group as compared to the progressing group (all p< 0.0001).

Conclusions : A significant proportion of patients with glaucoma in this large dataset showed visual field progression over time. Younger age and better MD, PSD and VFI at baseline were associated with greater risk of progression.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×